15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) protects neurons from oxidative death via an Nrf2 astrocyte-specific mechanism independent of PPARγ

被引:35
作者
Haskew-Layton, Renee E. [1 ]
Payappilly, Jimmy B. [1 ]
Xu, Hongbin [2 ,3 ,4 ]
Bennett, Steffany A. L. [2 ,3 ,4 ]
Ratan, Rajiv R. [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, Burke Med Res Inst, White Plains, NY 10605 USA
[2] Univ Ottawa, Neural Regenerat Lab, Ottawa, ON, Canada
[3] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada
[4] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada
关键词
astrocytes; neuroprotection; Nrf2; PPAR; vitamin E; ACTIVATED-RECEPTOR-GAMMA; SPINAL-CORD-INJURY; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); HEME OXYGENASE-1; CYCLOPENTENONE PROSTAGLANDINS; RESPONSIVE ELEMENTS; PHASE-2; ENZYMES; GENE-EXPRESSION; PC12; CELLS; VITAMIN-E;
D O I
10.1111/jnc.12107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Astrocytes are critical for the antioxidant support of neurons. Recently, we demonstrated that low level hydrogen peroxide (H2O2) facilitates astrocyte-dependent neuroprotection independent of the antioxidant transcription factor Nrf2, leaving the identity of the endogenous astrocytic Nrf2 activator to question. In this study, we show that an endogenous electrophile, 15-deoxy-?12,14-prostaglandin J2 (15d-PGJ2), non-cell autonomously protects neurons from death induced by depletion of the major antioxidant glutathione. Nrf2 knockdown in astrocytes abrogated 15d-PGJ2's neuroprotective effect as well as 15d-PGJ2 facilitated Nrf2-target gene induction. In contrast, knockdown of the transcription factor peroxisome proliferator activated-receptor gamma (PPAR?), a well-characterized 15d-PGJ2 target, did not alter 15d-PGJ2 non-cell autonomous neuroprotection. In addition, several PPAR? agonists of the thiazolidinedione (TZD) family failed to induce neuroprotection. Unexpectedly, however, the TZD troglitazone (which contains a chromanol moiety found on vitamin E) induced astrocyte-mediated neuroprotection, an effect which was mimicked by the vitamin E analogs alpha-tocopherol or alpha-tocotrienol. Our findings lead to two important conclusions: (i) 15d-PGJ2 induces astrocyte-mediated neuroprotection via an Nrf2 but not PPAR? mediated pathway, suggesting that 15d-PGJ2 is a candidate endogenous modulator of Nrf2 protective pathways in astrocytes; (ii) selective astrocyte treatment with analogs or compounds containing the chromanol moiety of vitamin E facilitates non-cell autonomous neuroprotection.
引用
收藏
页码:536 / 547
页数:12
相关论文
共 50 条
  • [21] 15-Deoxy-Δ12,14-prostaglandin J2 facilitates thyroglobulin production by cultured human thyrocytes
    Kasai, K
    Banba, N
    Hishinuma, A
    Matsumura, M
    Kakishita, H
    Matsumura, M
    Motohashi, S
    Sato, N
    Hattori, Y
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (06): : C1859 - C1869
  • [22] Proteomic Identification of Protein Targets for 15-Deoxy-Δ12,14-Prostaglandin J2 in Neuronal Plasma Membrane
    Yamamoto, Yasuhiro
    Takase, Kenkichi
    Kishino, Junji
    Fujita, Megumi
    Okamura, Noboru
    Sakaeda, Toshiyuki
    Fujimoto, Masafumi
    Yagami, Tatsurou
    PLOS ONE, 2011, 6 (03):
  • [23] Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 in human mesangial cells
    Zhang, XL
    Lu, L
    Dixon, C
    Wilmer, W
    Song, HJ
    Chen, XL
    Rovin, BH
    KIDNEY INTERNATIONAL, 2004, 65 (03) : 798 - 810
  • [24] Cytotoxicity of 15-Deoxy-Δ12,14-prostaglandin J2 through PPARγ-independent Pathway and the Involvement of the JNK and Akt Pathway in Renal Cell Carcinoma
    Fujita, Megumi
    Tohji, Chiaki
    Honda, Yoko
    Yamamoto, Yasuhiro
    Nakamura, Tsutomu
    Yagami, Tatsurou
    Yamamori, Motohiro
    Okamura, Noboru
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (07): : 555 - 566
  • [25] Side-modified 15-deoxy-Δ12,14-prostaglandin D2, precursor of corresponding PGJ2. Synthesis from cloprostenol and anticancer activity
    Vostrikov, Nikolay S.
    Lobko, Ilya F.
    Spirikhin, Leonid V.
    Vakhitova, Yulia V.
    Pivnitsky, Kasimir K.
    Miftakhov, Mansur S.
    MENDELEEV COMMUNICATIONS, 2017, 27 (02) : 125 - 127
  • [26] Effects of 15-Deoxy-Δ12,14-prostaglandin J2 on the Expression of p53 in MCF-7 Cells
    Kim, Do-Hee
    Kim, Eun-Hee
    Na, Hye-Kyung
    Surh, Young-Joon
    NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS, 2009, 1171 : 202 - 209
  • [27] 15-Deoxy-Δ12,14-Prostaglandin J2 Modifies components of the Proteasome and inhibits inflammatory responses in human endothelial cells
    Marcone, Simone
    Evans, Paul
    Fitzgerald, Desmond J.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [28] 15-deoxy-Δ12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells
    Schroeder, Oliver
    Yudina, Yulyana
    Sabirsh, Alan
    Zahn, Nadine
    Haeggstrom, Jesper Z.
    Stein, Juergen
    JOURNAL OF LIPID RESEARCH, 2006, 47 (05) : 1071 - 1080
  • [29] 15-Deoxy-Δ12,14-prostaglandin J2 modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes
    Lee, Eunsook
    Yin, Zhaobao
    Sidoryk-Wegrzynowicz, Marta
    Jiang, Haiyan
    Aschner, Michael
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 52 (06) : 1067 - 1074
  • [30] Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases
    Yagami, Tatsurou
    Yamamoto, Yasuhiro
    Koma, Hiromi
    MOLECULAR NEUROBIOLOGY, 2018, 55 (03) : 2227 - 2248